Rhpth (1-84)    (DrugBank: rhPTH)

1 disease
IDDisease name (Link within this page)Number of trials
235Hypoparathyroidism1

235. Hypoparathyroidism    [ 67 clinical trials,   112 drugs,   (DrugBank: 24 drugs),   4 drug target genes,   5 drug target pathways]
Searched query = "Hypoparathyroidism", "Accessory thyroid hypergasia disease"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 67 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1JPRN-JapicCTI-194828
31/3/202125/06/2019A Clinical Study of rhPTH (1-84) Treatment in Japanese Participants With Chronic HypoparathyroidismA Phase 3, Open-label Clinical Study of rhPTH (1-84) Treatment in Japanese Subjects With Chronic Hypoparathyroidism Chronic HypoparathyroidismIntervention name : rhPTH (1-84)
INN of the intervention : Parathyroid hormone
Dosage And administration of the intervention : rhPTH (1-84) will be administered at 25, 50, 75 and 100 micrograms once daily in one of the thighs (alternate thigh every day) as a subcutaneous injection.
Control intervention name : -
INN of the control intervention : -
Dosage And administration of the control intervention : -
Takeda Pharmaceutical Company LimitedNULLpending2085BOTH12Phase 3Japan